Epigenetic Strategies to Boost Cancer Immunotherapies.
Epigenetic Strategies to Boost Cancer Immunotherapies.
复制标题
DOI：
10.3390/ijms18061108
复制
发表时间：
2017-05-23
影响因子：
5.6
通讯作者：
Barrero MJ
中科院分区：
文献类型：
--
作者：
Barrero MJ
Recently, immunotherapeutic approaches have shown impressive responses in a subset of cancer patients. However, the rate of success is low and a large percentage of treated patients do not experience clinical benefits. Therefore, additional strategies are needed to improve responses and select responsive patients. Emerging data suggest that epigenetic drugs can improve the responses to immunotherapy. Understanding the mechanisms of resistance to immunotherapy and the epigenetic events that take place during immune evasion is critical to providing a rational combined use of immunotherapies and epigenetic drugs. This review focuses in the epigenetic mechanisms involved in the responses to immunotherapy and how current drugs that target epigenetic regulators impact on them.
